Table 1.

Correlative analysis of expression levels of IL‐33 and CD206 with clinicopathological factors

Features	n	IL‐33				CD206
		High	Low	χ2	P	High	Low	χ2	P
Age (y)
<65	55	34	21	0.169	.681	18	37	0.149	.7
≥65	28	16	12			8	20
Gender
Male	66	39	27	0.178	.673	19	47	0.964	.326
Female	17	11	6			7	10
G stage
G1	19	12	7	0.088	.767	3	16	2.765	.096
G2‐3	64	38	26			23	41
Location
Low	40	26	14	0.73	.393	14	26	0.485	.486
Middle to upper	43	24	19			12	31
TNM stage
Ⅰ‐Ⅱ stage	43	17	26	15.972	.001	8	35	6.711	.01
Ⅲ stage	40	33	7			18	22
T stage
1‐2	21	12	9	0.113	.737	6	15	0.099	.753
3‐4	62	38	24			20	42
N stage
N0	47	22	25	8.163	.004	10	37	5.086	.024
N1‐3	36	28	8			16	20